Photo: mcw.edu
Feb 1, 2026, 11:32
Qizhen Shi։ A Padua Moment for Factor VIII Gene Therapy
Qizhen Shi, Professor at Medical College of Wisconsin, Program Co-Leader of Thrombosis and Hemostasis at Versiti Blood Research Institute, shared on LinkedIn:
”Honored to share that my Blood Commentary, ‘A Padua moment for factor VIII gene therapy,’ has now been published.
The Commentary discusses a newly engineered FVIII variant with improved secretion and cofactor activity, offering a Padua-like advance for hemophilia A gene therapy by enabling efficacy at substantially lower vector doses.
Congratulations to the authors of the original study, and thank you to the Blood editorial team for the invitation.”
Stay updated with Hemostasis Today.
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’
-
Jun 29, 2026, 13:01Edward Lee Carter: Exploring Anticoagulation Paradox
-
Jun 29, 2026, 12:55Salvatore Massimo Petrina: When is it Truly Safe to Stop Anticoagulation after AF Ablation?
-
Jun 29, 2026, 12:44Sumedha Dash: Inspiring the Next Generation of Voluntary Blood Donors at CV Raman Global University
-
Jun 29, 2026, 12:35Dilini Christina Ranasinghe: Behind Every Unit of Blood